Novel Genetic Variations and Haplotypes of Hepatocyte Nuclear Factor 4α(HNF4A) Pound in Japanese Type II Diabetic Patients
-
- FUKUSHIMA-UESAKA Hiromi
- Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences
-
- SAITO Yoshiro
- Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences
-
- MAEKAWA Keiko
- Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences
-
- SAEKI Mayumi
- Project Team for Pharmacogenetics, National Institute of Health Sciences
-
- KAMATANI Naoyuki
- Division of Genomic Medicine, Department of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University
-
- KAJIO Hiroshi
- Division of Endocrine and Metabolic Diseases, the Hospital, International Medical Center of Japan
-
- KUZUYA Nobuaki
- Division of Endocrine and Metabolic Diseases, the Hospital, International Medical Center of Japan
-
- YASUDA Kazuki
- Department of Metabolic Disorder, Research Institute, International Medical Center of Japan
-
- SAWADA Jun-ichi
- Project Team for Pharmacogenetics, National Institute of Health Sciences Division of Biochemistry and Immunochemistry, National Institute of Health Sciences
書誌事項
- タイトル別名
-
- Novel Genetic Variations and Haplotypes of Hepatocyte Nuclear Factor 4.ALPHA.(HNF4A) Found in Japanese Type II Diabetic Patients
この論文をさがす
抄録
Thirty-nine single nucleotide variations, including 16 novel ones, were found in the 5′ promoter region, all of the exons and their surrounding introns of HNF4A in 74 Japanese type II diabetic patients. The following novel variations were identified (based on the amino acid numbering of splicing variant 2): -208G>C in the 5′ promoter region; 1154C>T (A385V) and 1193T>C (M398T) in the coding exons; 1580G>A, 1852G>T, 2180C>T, 2190G>A, and 2362_2380delAAGAATGGTGTGGGAGAGG in the 3′-untranslated region, and IVS1+231G>A, IVS2-83C>T, IVS3+50C>T, IVS3-54delC, IVS5+173_176delTTAG, IVS5-181_-180delAT, IVS8-106A>G, and IVS9-151A>C in the introns. The allele frequencies were 0.311 for 2362_2380delAAGAATGGTGTGGGAGAGG, 0.054 for 1580G>A, 0.047 for 1852G>T, 0.020 for IVS1+231G>A, 0.014 for IVS9-151A>C, and 0.007 for the other 11 variations. In addition, one known nonsynonymous single nucleotide polymorphism, 416C>T (T139I), was detected at a 0.007 frequency. Based on the linkage disequilibrium profiles, the region analyzed was divided into three blocks. Haplotype analysis determined/inferred 10, 16, and 12 haplotypes for block 1, 2, and 3, respectively. Our results on HNF4A variations and haplotypes would be useful for pharmacogenetic studies in Japanese.<br>
収録刊行物
-
- Drug Metabolism and Pharmacokinetics
-
Drug Metabolism and Pharmacokinetics 21 (4), 337-346, 2006
日本薬物動態学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205178762240
-
- NII論文ID
- 10018043031
-
- NII書誌ID
- AA1162652X
-
- ISSN
- 18800920
- 13474367
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可